论文部分内容阅读
作者重点介绍外科、放射治疗乳腺癌原发灶时,同时综合使用化疗、内分泌、免疫疗法治疗潜在的远处转移灶问题。腋下淋巴结的情况对生存率有显著影响,腋下有1～3个淋巴结转移,复发平均间隔时间为5年;腋下有4个以上淋巴结转移时,50%患者在18个月复发。总起来,腋下有淋巴结转移者,复发的中数时间为3年。最近有人报告从10年后复发率看来,腋下淋巴结阴性患者为24%,腋下淋巴结阳性患者为75%。
The authors focus on the use of chemotherapy, endocrinology, and immunotherapy for the treatment of potential distant metastases when surgically and radiologically treating primary breast cancer. The condition of the axillary lymph nodes had a significant effect on the survival rate, with 1 to 3 lymph node metastases in the armpit and the average interval between recurrences was 5 years. When there were more than 4 lymph node metastases in the armpit, 50% of patients relapsed at 18 months. In general, if there is lymph node metastasis in the armpit, the median time to relapse is 3 years. Recently, it was reported that from the recurrence rate after 10 years, 24% of patients with axillary lymph node-negative patients and 75% with axillary lymph node-positive patients.